Most Recent Research
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional C... - PubMed - NCBI
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
The Benefits of Customized DNA Directed Nutrition To Balance The Brain Reward Circuitry And Reduce Addictive Behaviors - PubMed - NCBI
Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Pattern - PubMed - NCBI
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. - PubMed - NCBI
Global Opioid Epidemic: Doomed To Fail Without Genetically Based Precision Addiction Medicine (Pam™): Lessons Learned From America. - PubMed - NCBI
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). - PubMed - NCBI
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional C... - PubMed - NCBI
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
The Benefits of Customized DNA Directed Nutrition To Balance The Brain Reward Circuitry And Reduce Addictive Behaviors - PubMed - NCBI
Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Pattern - PubMed - NCBI
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. - PubMed - NCBI
Global Opioid Epidemic: Doomed To Fail Without Genetically Based Precision Addiction Medicine (Pam™): Lessons Learned From America. - PubMed - NCBI
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). - PubMed - NCBI
Earlier KB220Z Research
Reward Deficiency Syndrome Studies of KB220 Variants and Molecular Neurobiology
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. - PubMed - NCBI
Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? - PubMed - NCBI
Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? - PubMed - NCBI
Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. - PubMed - NCBI
The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. - PubMed - NCBI
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery La... - PubMed - NCBI
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. - PubMed - NCBI
Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case. - PubMed - NCBI
Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. - PubMed - NCBI
KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes... - PubMed - NCBI
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. - PubMed - NCBI
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative d... - PubMed - NCBI
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy... - PubMed - NCBI
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? - PubMed - NCBI
Pro-Dopamine Regulator - (KB220Z) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. - PubMed - NCBI
Click here for Clinical Studies from 1973-2016
Click here to read Testimonials
Reward Deficiency Syndrome Studies of KB220 Variants and Molecular Neurobiology
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. - PubMed - NCBI
Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? - PubMed - NCBI
Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? - PubMed - NCBI
Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. - PubMed - NCBI
The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. - PubMed - NCBI
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery La... - PubMed - NCBI
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. - PubMed - NCBI
Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case. - PubMed - NCBI
Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. - PubMed - NCBI
KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes... - PubMed - NCBI
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. - PubMed - NCBI
Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative d... - PubMed - NCBI
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy... - PubMed - NCBI
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? - PubMed - NCBI
Pro-Dopamine Regulator - (KB220Z) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). - PubMed - NCBI
The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. - PubMed - NCBI
Click here for Clinical Studies from 1973-2016
Click here to read Testimonials